July 12, 2014 6:21 PM ET

Pharmaceuticals

Company Overview of Fresenius Kabi Pharmaceuticals Holding, Inc.

Company Overview

Fresenius Kabi Pharmaceuticals Holding, Inc. develops, manufactures, and markets injectable pharmaceutical products in North America. Its oncology products include Carboplatin for the advanced ovarian carcinoma; Doxorubicin for breast cancer; Fludarabine for B-cell chronic lymphocytic leukemia; Fluorouracil to inhibit the growth of cancer cells; Ifosfamide to treat germ cell testicular cancer; Irinotecan for cancer of the large intestine and rectum; Mesna for the side effects related to chemotherapy drugs; Paclitaxel Injection for the carcinoma of the ovary and non-small cell lung cancer; Cisplatin Injection for metastatic testicular tumors; Oxaliplatin; and Topotecan for Injection for small...

Else-Kroener-Strasse 1

Bad Homburg vdh

Bad Homburg,  61352

Germany

Founded in 1996

1,472 Employees

Phone:

49 6172 608 0

Key Executives for Fresenius Kabi Pharmaceuticals Holding, Inc.

Chief Executive Officer
Chief Operating Officer and Executive Vice President
Age: 59
President of Abraxis BioCapital
Age: 62
Chief Scientific Officer and Executive Vice President
Age: 53
Senior Vice President of Manufacturing
Age: 73
Compensation as of Fiscal Year 2014.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Fresenius Kabi Pharmaceuticals Holding, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.